Clinical Trial Update: Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 trial update for Taclonex ointment with hydrogel patch occlusion in psoriasis; study terminated with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis
• Psoriasis Vulgaris

Drugs mentioned

• TACLONEX (calcipotriol and betamethone dipropionate)

Snippet

Sponsor: University of California, San Francisco | Conditions: Plaque Psoriasis, Psoriasis Vulgaris | Phase 4 | Status: TERMINATED | Results posted: 2012-12-05